Intellectual Property India Publishes Patent Application for 'Sars-Cov-2 Spike Protein-Binding Molecules' Filed by National University Of Singapore

MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202517069357 A) filed by National University Of Singapore, Singapore, on July 21, for 'sars-cov-2 spike protein-binding molecules.'

Inventor(s) include Wang, Linfa; Chia, Wan Ni; Tan, Chee Wah; and Zhu, Feng.

The application for the patent was published on Nov. 14, under issue no. 46/2025.

According to the abstract released by the Intellectual Property India: "SARS-CoV-2 spike protein-binding molecules are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using, the SARS-CoV-2 spike protein-binding molecules."

The patent application was internationally filed on Dec. 20, 2023, under International application No.PCT/EP2023/087111.

Disclaimer: Curated by HT Syndication.